Chinese authorities have issued guidelines recommending Roche’s anti-inflammation drug Actemra to combat severe complications caused by the COVID-19 coronavirus.
Boehringer Ingelheim and Carebox Healthcare Solutions have launched a digital platform aimed at giving patients, families, caregivers and doctors the opportunity to learn ab